Pharmacological and Nonpharmacological Treatment of Insomnias, Parasomnias, and Circadian Rhythm Disorders Associated With ADHD

section epub:type=”chapter”>



Pharmacological and Nonpharmacological Treatment of Insomnias, Parasomnias, and Circadian Rhythm Disorders Associated With ADHD



Marco Angriman1 and Samuele Cortese2,3,4,5,    1Child Neurology and Neurorehabilitation Unit, Department of Pediatrics, Hospital of Bolzano, Bolzano, Italy,    2Center for Innovation in Mental Health, Academic Unit of Psychology and Clinical and Experimental Sciences (CNS and Psychiatry), Faculty of Medicine, University of Southampton, Southampton, United Kingdom,    3Solent NHS Trust, Southampton, United Kingdom,    4New York University Child Study Center, New York, NY, United States,    5Division of Psychiatry and Applied Psychology, School of Medicine, University of Nottingham, Nottingham, United Kingdom


Abstract


Sleep disturbances are frequent in attention deficit hyperactivity disorder (ADHD). Sleep complaints in individuals with ADHD may be due to behavioral factors (such as limit setting disorder), specific primary sleep disorders (including primary insomnia, delayed sleep phase disorder, parasomnias, restless legs syndrome, and sleep disordered breathing), the effect of the pharmacological treatment, or comorbid disorders. Therefore, sleep disturbances should be systematically screened for at each visit with patients referred for ADHD by means of subjective or objective tools. Empirical evidence for the treatment of sleep disturbances associated with ADHD is currently limited, although some trials show the efficacy/effectiveness and good tolerability of melatonin for sleep onset delay and a few studies provide support to behavioral interventions. Here, we provide an overview of the main sleep disturbances/disorders associated with ADHD, their diagnostic assessment and available therapeutic options. Our therapeutic recommendations are based on the integration of existing empirical evidence with our clinical experience.


Keywords


ADHD; sleep; medications; behavioral therapies; evidence-base


9.1 Practical Points





9.2 Introduction


Attention deficit/hyperactivity disorder (ADHD) is a common childhood-onset psychiatric condition, characterized, according to the DSM-5 criteria (American Psychiatric Association, 2013), by impairing and pervasive core symptoms of inattention and/or hyperactivity–impulsivity. Impairing symptoms of ADHD persist into adulthood in as many as 65% of cases (Mannuzza, Klein, & Moulton, 2003). The association between ADHD and other psychiatric or neurodevelopmental conditions such as oppositional defiant disorder (ODD), conduct disorder (CD), and mood/anxiety disorders, is well-established (Biederman & Faraone, 2005).


Conversely, the relationship between ADHD and sleep disturbances has been largely overlooked, both from a research standpoint and in clinical practice. This is reflected by the lack of specific recommendations on sleep assessment in a number of previous guidelines and practice parameters on ADHD over the last decade (Pliszka & AACAP Work Group on Quality Issues, 2007). However, sleep problems are an important factor to consider in the assessment and management of patients with ADHD. Indeed, when asked, parents of children with ADHD do report sleep problems in their children in a sizable portion of cases. According to Corkum, Tannock, & Moldofsky, 1998, parents report sleep problems in 25%–50% of children with ADHD, compared with 7% of normal controls. Considering also mild (besides severe) sleep alterations, 70% of children with ADHD have been found to present with a parent-reported sleep problem (Sung, Hiscock, Sciberras, & Efron, 2008). Of note, in more recent years there has been an increasing awareness of sleep problems in children with ADHD, as reflected by the inclusion of sleep evaluation in some of the more recent ADHD guidelines and consensus statements, both in children and in adults (Kooij et al., 2010; Subcommittee on Attention-Deficit/Hyperactivity Disorder et al., 2011; Díaz-Román 2016).


Addressing sleep issues in patients referred for ADHD symptoms is of particular relevance for three reasons (Konofal, Lecendreux, & Cortese, 2010): (1) Sleep disturbances may represent a significant source of distress for the child and/or the family; (2) sleep problems may worsen ADHD symptoms as well as associated mood and emotional disorders; and (3) quantitative or qualitative alterations of sleep may cause problems with mood, attention, and behavior, so that sleep disturbances may mimic ADHD symptoms and result in misdiagnosis of children with ADHD. Therefore, symptoms of inattention, hyperactivity and/or impulsivity may be improved or even eliminated with treatment of the primary sleep disorder.


Sleep dysfunction in individuals with ADHD is underpinned by a multifactorial etiopathophysiology (Pliszka & AACAP Work Group on Quality Issues, 2007). As a consequence, the management needs to be tailored to the specific factors underlying sleep disturbances. In this chapter, addressed mainly to clinicians, we provide an overview of the main sleep disturbances/disorders associated with ADHD, their diagnostic assessment and available therapeutic options. We base our therapeutic recommendations on existing empirical evidence, integrating it with our clinical experience when no or limited empirical data are available.


9.3 Sleep Disturbances Associated With ADHD


Sleep can be assessed by means of so-called “subjective methods,” that is, clinical interviews or questionnaires filled out by the patient (in pediatric settings, by the parents or, less frequently, by the children themselves) or “objective” methods, that is, using neurophysiological tools such as polysomnography (PSG), actigraphy, infrared video analysis, and the multiple sleep latency test (MSLT). Several subjective (e.g., Mick, Biederman, Jetton, & Faraone, 2000) as well as objective sleep studies (e.g., Kirov, Banaschewski, Uebel, Kinkelbur, & Rothenberger, 2007) have been conducted in ADHD. It is unpractical to review all these studies here. Fortunately, meta-analytic evidence pooling all pertinent studies is available, both for studies including children and adults. In our review, we found evidence that children with ADHD present with significantly more sleep problems than youth without ADHD as reported by parents, including bedtime resistance, sleep onset difficulties, night awakenings, difficulties with morning awakenings, sleep disordered breathing (SDB), and daytime sleepiness (Cortese, Faraone, Konofal, & Lecendreux, 2009). We also found that children with ADHD were significantly more compromised than comparisons in several parameters from objective studies, such as sleep onset latency (on actigraphy), the number of stage shifts/hour sleep, the apnea–hypopnea index, and sleep efficiency on PSG, true sleep time on actigraphy, and average times to fall asleep for the MSLT than the comparisons (indicating that children with ADHD have higher levels of daytime sleepiness than comparisons). Of note, we excluded studies assessing children pharmacologically treated or with comorbid anxiety/depressive disorders, thus suggesting that the significant differences in sleep parameters (both subjective and objective) are not accounted for exclusively by ADHD medications or psychiatric comorbidities, although of course these factors may and do impact sleep in children with ADHD (see Table 9.1 for suggestions on how to manage sleep problems possibly associated with ADHD medication use). As for adults, a more recent meta-analysis found that, compared to adults without ADHD, those with ADHD significantly differed in seven out of nine subjective parameters and two out of five actigraphic parameters (sleep onset latency and sleep efficiency) (Díaz-Román, Mitchell, & Cortese, 2018).



In the following sections, we discuss the assessment and the management of sleep disturbances in individuals with ADHD.


9.4 Assessment of Sleep and Sleep Disturbances in Patients Referred for ADHD Symptoms


Given the association between sleep disturbances and ADHD, we suggest to systematically screen for sleep problems at first visit as well as at each visit of follow-up. Based on the aforementioned considerations, it is paramount to systematically inquire for sleep problems not only in patients with an established diagnosis of ADHD, but also in those referred for symptoms of inattention and/or hyperactivity–impulsivity, in order to rule out possible sleep disorders such as restless leg syndrome (RLS) or SDB that may mimic ADHD. A simple screening can be implemented using a series of open, unstructured questions (see Chapter 8). The following aspects should be inquired: bedtime resistance, sleep onset difficulty, night awakenings, difficulty with morning awakenings, SDB, and daytime sleepiness. Besides clinical interviews, several tools are available to help the clinician screen for sleep problems and orient further assessment. For children, these include the Sleep Disturbance Scale for Children (Bruni et al., 1996), the Pediatric Sleep Questionnaire (Chervin, Hedger, Dillon, & Pituch, 2000), and the Children’s Sleep Habit Questionnaire (Owens, Spirito, & McGuinn, 2000). We note that these questionnaires do not include a systematic screening for RLS, in part because this syndrome has been described in children only recently. In this regard, the clinician can refer to the criteria for RLS proposed at the 1995 restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health (Allen et al., 2003), as well as the recent Pediatric Restless Legs Syndrome Severity Scale (P-RLS-SS) (children and parent version) (Arbuckle et al., 2010), which allows the quantification of the severity and the impact of RLS symptoms in children. For adults, screening tools include the Pittsburgh Sleep Quality Index (Buysse, Reynolds, Monk, Berman, & Kupfer, 1989), the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome (Netzer, Stoohs, Netzer, Clark, & Strohl, 1999) and the Epworth sleepiness scale (Johns, 1991) for measuring daytime sleepiness (see Chapter 8). Besides questionnaires, another subjective tool is the sleep diary (somnolog, see also Chapter 8), where the patient (or the parents in case of children) records sleeping and waking times over a period of some weeks (in our experience: 3 weeks). It is relatively feasible to incorporate each of the aforementioned subjective tools in the first as well as the follow-up visits. We suggest performing a PSG recording if there is a suspicion of SDB, nocturnal convulsions, sleep related causes of excessive daytime sleepiness or sleep fragmentation due to frequent nocturnal arousals (including Periodic Limb Movement Disorder, see Chapter 8). MSLT preceded by all-night PSG should be considered to evaluate daytime sleepiness secondary to sleep alterations or as an expression of a primary alteration of arousal as well as to rule out narcolepsy as a differential diagnosis


Clearly, referred patients present not with a diagnosis of sleep disorder but with sleep complaints which are nonspecific. For example, bedtime resistance, which, in our experience, is the most common sleep complaint associated with ADHD, may be due to limit setting disorder, RLS, delayed sleep phase onset, or anxiety. Thus, the appropriate management of sleep complaints in patients with ADHD relies on the correct identification and treatment of sleep disorder(s) or alterations underlying these complaints. In this regard, the goal is to perform an accurate diagnosis using subjective and, when necessary, objective tools. For the diagnosis, we refer to the criteria of the International Classification of Sleep Disorders, third edition (American Academy of Sleep Medicine, 2014), which includes also specific criteria for children. The therapeutic strategies of sleep complaints should be tailored to the specific underlying disorder. In our experience, it is not infrequent to find ADHD patients with more than one sleep disorder (e.g., limit setting disorder and sleep phase delay).


9.5 Treatment of Sleep Disturbances in Individuals With ADHD


The above-mentioned sleep complaints may be underpinned by a number of disorders/conditions, which need to be considered when starting a care plan, as detailed in the next sections.


9.5.1 Primary Insomnia


Pediatric insomnia is defined as a “repeated difficulty with sleep initiation, duration, consolidation, or quality that occurs despite age-appropriate time and opportunity for sleep and results in daytime functional impairment for the child and/or family” (Bruni, & Angriman, 2015).


The DSM-5 integrated pediatric and developmental criteria and also replaced “primary insomnia” with the diagnosis of “insomnia disorder,” a switch to avoid the primary/secondary designation when this disorder co-occurs with other conditions and to reflect changes throughout the classification. Furthermore, it introduced a temporal criterion (more than 3 “bad nights” a week for the last 3 months). DSM-5 underscores the need for independent clinical attention of a sleep disorder regardless of mental or other medical problems that may be present (American Psychiatric Association, 2013).


Behavioral interventions are the main nonpharmacological methods for ADHD children with primary insomnia and include sleep hygiene and cognitive behavioral therapy (LeBourgeois, Giannotti, Cortesi, Wolfson, & Harsh, 2005). Sleep hygiene or healthy sleep practices (see Chapter 5) includes establishment of consistent behavior surrounding bedtime to promote productive and restful sleep, a stable bedtime, and regular wake time (Bruni & Angriman, 2015). Cognitive behavioral therapy includes a combination of relaxation training, stimulus control therapy, sleep restriction, and cognitive therapies. Following an expert consensus, in 2013 Cortese et al. recommended behavioral interventions as the first-line treatment for children with ADHD and insomnia, but pointed to the need for more research given the limited amount of evidence at the time (Cortese et al., 2013; Sciberras, Fulton, Efron, Oberklaid, & Hiscock, 2011; Um et al., 2016). Since 2012, important RCTs have been published (see Table 9.2). Corkum et al. (2016) aimed to assess the efficacy of a five-session manualized behavioral intervention for sleep problems in children with or without ADHD. The study showed that sleep of children randomized to the study intervention was rated as significantly more improved by parents, compared to the control group assigned to waitlist, at 2-month and 6-month follow-up. Additionally, actigraphic evaluation confirmed a significant reduction of sleep onset latency, albeit without a significant increase in total sleep time, in the active treatment group.



Table 9.2










































RCTs on behavioral sleep strategies for ADHD
First author and year Country Patients (n) Age (years) Controls Outcome Follow up period (months) Sleep assessment
Corkum (2016) Canada 31 5–12 30 Significant reduction in sleep problems and improved psychosocial functioning at postintervention and follow-up 6 Questionnaires and actigraphy
Keshavarzi (2014) Iran 40 Not reported 20 The intervention group children reported improvements in mood, emotions, and relationships 3 Questionnaires
Hiscock (2015) Australia 122 5–12 122 Intervention modestly improves the severity of ADHD symptoms, children’s sleep, behavior, quality of life, and functioning 6 Questionnaires and actigraphy


Image


Another important RCT, conducted by Hiscock and colleagues (2015), assessed the efficacy of a short intervention, based on sleep hygiene practices and behavioral strategies delivered during two fortnightly consultations and a follow-up telephone call. Compared to those assigned to usual care, children randomized to the active intervention presented with significantly fewer moderate and severe sleep problems (as reported by the caregiver) after three months (estimated number needed to treat, NTT: 3.9) and six months (estimated NTT: 7.8).


Additionally, in another RCT, Keshavarzi et al. (2014) examined the efficacy of behavioral sleep interventions, based on parent training. At the endpoint (12 weeks), sleep problems of children whose parents participated in a sleep training behavioral program were rated as significantly more improved, compared to sleep problems of children whose parents were randomized to the control intervention (one session on sleep hygiene).


The use of a sleep-promoting medication could be considered for those children without significant improvement after both behavioral interventions and adjusting primary ADHD medications. Indeed, approximately one in five children with ADHD take sleep medications (Efron, Lycett, & Sciberras, 2014), the most common being melatonin and clonidine (Golmirzaei et al., 2016). However, neither are approved by the American Food and Drug Administration (FDA). Melatonin has been increasingly used for ADHD children in recent years (Furster, & Hallerbäck, 2015), and about half of the young children stay on melatonin treatment for several years.


Current data suggest that melatonin is a well-tolerated and efficacious treatment option for pediatric patients with chronic sleep-onset insomnia and ADHD (Bendz, & Scates, 2010). However, melatonin was found to be associated with earlier waking times in a randomized, double masked placebo-controlled trial (Gringras et al., 2012). Table 9.3 reports a summary of studies on melatonin for sleep problems in children and adolescents with ADHD.



Table 9.3





































































RCTs on melatonin in ADHD
First author and year Country Patients (n) Age (years) Doses Sleep assessment
Appleton (2012) UK 110 3–15 0.5–12 mg Sleep log and actigraphy
Dodge 2001 USA 20 1–12 5 mg Sleep log
Hoebert (2009) The Netherlands 101 6–12 3–6 mg Questionnaire
Mohammadi (2012) Iran 50 7–12 3 or 6 mg Sleep log
Tjon Pian (2003) The Netherlands 24 n.r. n.r. Sleep log
Van der Heijden (2007) The Netherlands 105 6–12 3–6 mg Sleep log and actigraphy
Wasdell (2008) Canada 50 2–18 1–4 mg Sleep log and actigraphy
Weiss (2006) Canada 19 6–14 5 mg Sleep log and actigraphy

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jun 13, 2021 | Posted by in PSYCHOLOGY | Comments Off on Pharmacological and Nonpharmacological Treatment of Insomnias, Parasomnias, and Circadian Rhythm Disorders Associated With ADHD

Full access? Get Clinical Tree

Get Clinical Tree app for offline access